Prostate Cancer - Results from #23920

GU Cancers Symposium 2013 - Treatment and surveillance of prostate cancer patients - Symposium Summary February 14, 2013

Impact of rectal balloon-filling materials on the dosimetry of prostate and organs at risk in photon beam therapy - Abstract February 14, 2013

Comparisons of perioperative outcomes and costs between open and laparoscopic radical prostatectomy: A propensity-score matching analysis based on the Japanese Diagnosis Procedure Combination database - Abstract February 14, 2013

Access to information and expectations of treatment decisions for prostate cancer patients - results of a European survey - Abstract February 14, 2013

Endocrine therapy in prostate cancer: Time for reappraisal of risks, benefits and cost-effectiveness? - Abstract February 14, 2013

How surgical innovation reduced death and suffering from prostate cancer - Abstract February 14, 2013

Early results of prostate cancer radiation therapy: An analysis with emphasis on research strategies to improve treatment delivery and outcomes - Abstract February 14, 2013

A review of emerging strategies for optimizing the clinical impact of immunotherapeutic agents in prostate cancer February 14, 2013

Landmark survey of prostate biopsies confirms sampling standard February 14, 2013

Clinical appraisal of abiraterone in the treatment of metastatic prostatic cancer: Patient considerations, novel opportunities, and future directions - Abstract February 13, 2013

Dosimetric assessment of prostate cancer patients through principal component analysis (PCA) - Abstract February 13, 2013

Risk stratification after biochemical failure following curative treatment of locally advanced prostate cancer: Data from the TROG 96.01 trial - Abstract February 13, 2013

Trans-anal rectoscopic ball diathermy (TARD) for radiotherapy induced haemorrhagic telangectasia : A safe and effective treatment - Abstract February 13, 2013

Diagnostic tests in urology: Magnetic resonance imaging (MRI) for the staging of prostate cancer - Abstract February 13, 2013

Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort - Abstract February 13, 2013

Changes in serum prostate-specific antigen levels and the identification of prostate cancer in a large managed care population - Abstract February 13, 2013

Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria - Abstract February 13, 2013

Research from the 2013 Genitourinary Cancers Symposium highlights new insights on high-risk prostate cancer prevalence and treatment, compares benefit of surveillance and surgery for management of small kidney tumors February 13, 2013

Masculinities and patient perspectives of communication about active surveillance for prostate cancer - Abstract February 13, 2013

Familial prostate cancer: The damage done and lessons learnt - Abstract February 12, 2013

Page 1197 of 1439